Clinical trial
A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast…
NCT00159094 · Hematology Oncology Consultants, Other · Unknown status
Key facts
| NCT number | NCT00159094 |
|---|---|
| Title | A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer |
| Official title | A Phase II Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer |
| Lead sponsor | Hematology Oncology Consultants, Other |
| Collaborators | Ortho Biotech, Inc. Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | Doxil and Vinorelbine |
| Enrollment | 30 |
| Start date | Oct 1, 2003 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 2, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: